Clinical TrialEfficacy and safety of bevacizumab-containing neoadjuvant therapy followed by interval debulking surgery in advanced ovarian cancer: Results from the ANTHALYA trial☆
Under a Creative Commons license
open access
Keywords
Bevacizumab
Interval debulking surgery
Neoadjuvant chemotherapy
Cited by (0)
- ☆
This work was presented in part at the 2015 Annual Meeting of the European Society for Medical Oncology (Selle F, et al. ESMO 2015 Poster presentation (Abstract 2766)) and the 2015 meeting Annual Meeting of the European Society of Gynaecological Oncology (Gouy S, et al. ESGO poster presentation).
© 2016 The Authors. Published by Elsevier Ltd.